Dupixent 200Mg (175Mg/Ml) C/2 Seringas Preenchidas (1,14Ml)
Dupilumabe is a solution for injectable use containing 200 mg of dupilumab, indicated for moderate to severe atopic dermatitis, severe asthma with eosinophilic phenotype, and chronic rhinosinusitis with nasal polyps.
- The description claims Dupilumabe inhibits IL-4 and IL-13, which are important in the inflammatory process.
AI Readiness
Good foundation, but some important product data is still missing.
80%